Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tonato

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
Pharmacoeconomics|February 7, 1994
Cost and cost-effectiveness analysis of ondansetron versus metoclopramide regimens: a hospital perspective from ItalyE Ballatori, F Roila, P Berto, et al.
Cancer Investigation|January 1, 1990
Combination therapy with platinum and etoposide of brain metastases from breast carcinomaG Cocconi, R Lottici, G Bisagni, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 1998
Chemotherapy with cisplatin and teniposide for cerebral metastases in non-small cell lung cancerV Minotti, L Crinò, M L Meacci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1997
A better therapeutic profile for the combination of mitomycin-C, ifosfamide and cisplatin (MIC) in advanced non-small-cell lung cancer: a useful dose-schedule modificationL Crinò, E Corgna, S Porrozzi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
OndansetronF Roila, M Tonato, C Basurto, et al.
Seminars in Oncology|December 1, 1996
Preliminary results of a dose-finding study of paclitaxel and carboplatin in patients with advanced non-small cell lung cancerG V Scagliotti, L Crinó, E Pozzi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Double-blind crossover trial of single vs. divided dose of metoclopramide in a combined regimen for treatment of cisplatin-induced emesisF Roila, C Basurto, S Bracarda, et al.
American Journal of Clinical Oncology|April 1, 1992
Antiemetic activity of two different high doses and schedules of metoclopramide in dacarbazine-treated cancer patientsF Roila, S Bracarda, C Basurto, et al.
Haematologica|June 1, 1979
Treatment of acute nonlymphocytic leukemia (ANLL) in elderly patients. Results of a multicentric studyF Mandelli, S Amadori, F Fabiani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical ResearchF Roila, M Tonato, C Basurto, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
Pharmacoeconomics|February 7, 1994
Cost and cost-effectiveness analysis of ondansetron versus metoclopramide regimens: a hospital perspective from ItalyE Ballatori, F Roila, P Berto, et al.
Cancer Investigation|January 1, 1990
Combination therapy with platinum and etoposide of brain metastases from breast carcinomaG Cocconi, R Lottici, G Bisagni, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 1998
Chemotherapy with cisplatin and teniposide for cerebral metastases in non-small cell lung cancerV Minotti, L Crinò, M L Meacci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1997
A better therapeutic profile for the combination of mitomycin-C, ifosfamide and cisplatin (MIC) in advanced non-small-cell lung cancer: a useful dose-schedule modificationL Crinò, E Corgna, S Porrozzi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
OndansetronF Roila, M Tonato, C Basurto, et al.
Seminars in Oncology|December 1, 1996
Preliminary results of a dose-finding study of paclitaxel and carboplatin in patients with advanced non-small cell lung cancerG V Scagliotti, L Crinó, E Pozzi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Double-blind crossover trial of single vs. divided dose of metoclopramide in a combined regimen for treatment of cisplatin-induced emesisF Roila, C Basurto, S Bracarda, et al.
American Journal of Clinical Oncology|April 1, 1992
Antiemetic activity of two different high doses and schedules of metoclopramide in dacarbazine-treated cancer patientsF Roila, S Bracarda, C Basurto, et al.
Haematologica|June 1, 1979
Treatment of acute nonlymphocytic leukemia (ANLL) in elderly patients. Results of a multicentric studyF Mandelli, S Amadori, F Fabiani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical ResearchF Roila, M Tonato, C Basurto, et al.
Pageof 12